Cyclic PSAP peptide
Cyclic PSAP peptide (DWLPK) exhibits therapeutic potential by inhibiting metastatic spread and suppressing tumor growth in vivo. This makes it a relevant tool for oncology research, particularly in studies of cancer cell migration, invasion, and tumor progression in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog